Cite
Benralizumab-induced interstitial granulomatous dermatitis: A case report
MLA
Mankouri, Farid, et al. “Benralizumab-Induced Interstitial Granulomatous Dermatitis: A Case Report.” Thérapie, vol. 78, no. 4, July 2023, pp. 457–59. EBSCOhost, https://doi.org/10.1016/j.therap.2022.09.006.
APA
Mankouri, F., Gosse, L., Handwerk, T., Guyot, B., Pahus, L., Chanez, P., Abed, S., Boye, T., Morand, J.-J., & Valois, A. (2023). Benralizumab-induced interstitial granulomatous dermatitis: A case report. Thérapie, 78(4), 457–459. https://doi.org/10.1016/j.therap.2022.09.006
Chicago
Mankouri, Farid, Laurie Gosse, Tom Handwerk, Benjamin Guyot, Laurie Pahus, Pascal Chanez, Safia Abed, Thierry Boye, Jean-Jacques Morand, and Aude Valois. 2023. “Benralizumab-Induced Interstitial Granulomatous Dermatitis: A Case Report.” Thérapie 78 (4): 457–59. doi:10.1016/j.therap.2022.09.006.